The Pompe disease market is estimated to change significantly during the forecast period (2026–2036), owing to the launch of novel...
- Encaleret administration increased bone turnover, based on its action to recover endogenous PTH secretion in patients with ADH1 -...
Chief Medical Officer Dr. Sam Barone to join the Emerging Innovations in Retinal Therapies panel; Company to present an update...
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Glycogen Storage Disorder Type 1A ORLANDO, FL...
Samarendra Mohanty, Co-Founder, President and Chief Scientific Officer, to participate in the premier cell and gene therapy industry conference, October...
Samarendra Mohanty, Co-Founder, President and Chief Scientific Officer, to participate in the premier cell and gene therapy industry conference, October...
Proposed Acquisition Valued at Approximately $15 Million Would Add an Established 50-State Telehealth Business, with over 90,000 clients, Focused on...
MyOme's predictive genomic insights that support proactive healthcare run on Oracle Cloud Infrastructure MENLO PARK, Calif., Sept. 24, 2026 /PRNewswire/...
A redesigned patient experience drives engagement from prevention through survivorship, while chart-aware risk intelligence surfaces guideline-based recommendations in EHR workflowsCHICAGO,...
Ottawa, Ontario and Richmond Hill, Ontario--(Newsfile Corp. - September 15, 2026) - La Vie Health ("La Vie") and Virotek Biosciences...
Multi-year research collaboration will focus initially on AML and MDS while advancing Electronic Genome Mapping for broader hematologic research applicationsPROVIDENCE,...
BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming...
The Global Fertility Sensor Market fueled by rising consumer demand for sensor-enabled ovulation tracking and conception planning tools. Wearable fertility...
The Global Fertility Sensor Market fueled by rising consumer demand for sensor-enabled ovulation tracking and conception planning tools. Wearable fertility...
Quest Diagnostics and Getlabs strengthen Attunio's AI-powered, biomarker-driven infrastructure with blood and genetic testing from homeATLANTA, June 25, 2026 /PRNewswire/...
RareDAI follows a clinician's chain-of-thought, allowing for reproducibility based on a series of standardized questionsPHILADELPHIA, June 24, 2026 /PRNewswire/ --...
Global awareness campaign highlights the importance of genetic diagnosis in an era of rapidly advancing genetic medicineLOS ANGELES, June 24,...
Now available directly to patients, MyPhenome is the first and only precision obesity test that goes beyond GLP-1 treatment response...
Now available directly to patients, MyPhenome is the first and only precision obesity test that goes beyond GLP-1 treatment response...
DALLAS, June 16, 2026 /PRNewswire/ -- Cizzle Bio, Inc., a Texas-based biotechnology company advancing biomarker blood tests for early detection of...